Prognostic Enigma of Pancreatic Solid Pseudopapillary Neoplasm: A Single-Center Experience of 63 Patients

Background: Studies investigating prognostic factors of solid pseudopapillary neoplasm (SPN) have been published with conflicting findings.Methods: Retrospective analysis of 63 consecutive cases of SPN in our institution from January 2010 to December 2019 was carried out. The clinicopathological fea...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Xinbo Wang, Daojun Zhu, Wei Bao, Min Li, Sizhen Wang, Rongxi Shen
Formato: article
Lenguaje:EN
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://doaj.org/article/c49cef4a9fb54fb19e9e30fbb79a144a
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:c49cef4a9fb54fb19e9e30fbb79a144a
record_format dspace
spelling oai:doaj.org-article:c49cef4a9fb54fb19e9e30fbb79a144a2021-11-22T05:12:26ZPrognostic Enigma of Pancreatic Solid Pseudopapillary Neoplasm: A Single-Center Experience of 63 Patients2296-875X10.3389/fsurg.2021.771587https://doaj.org/article/c49cef4a9fb54fb19e9e30fbb79a144a2021-11-01T00:00:00Zhttps://www.frontiersin.org/articles/10.3389/fsurg.2021.771587/fullhttps://doaj.org/toc/2296-875XBackground: Studies investigating prognostic factors of solid pseudopapillary neoplasm (SPN) have been published with conflicting findings.Methods: Retrospective analysis of 63 consecutive cases of SPN in our institution from January 2010 to December 2019 was carried out. The clinicopathological features, treatment practices along with survival associations were collected and analyzed.Results: Fifteen patients (23.8%) were male, and 48 (76.2%) were female, with a median age of 34.0 ± 14.5 years. The larger tumor size was correlated with the more mixed components (p = 0.000) and the higher Ki-67 index (p = 0.042). No recurrence was found in the nine patients whose tumors fulfilled the WHO criteria for malignancy due to the presence of at least perineural invasion (6.4%), angiovascular invasion (2.3%), and/or adjacent organ invasion (6.4%). Microscopic infiltrative growth was detected in 9 (14.3%) tumors, which was correlated significantly with the WHO criteria (p = 0.002), capsule invasion (p = 0.005), and pancreatic parenchyma invasion (p = 0.001), but not with disease-free survival (p = 0.13). CD99 was found to be positively expressed in 88.9% (40/45) of tumors and more likely to have depressed Ki-67 index (p = 0.016). After a median follow-up of 58 months, only two patients (3.2%) had a recurrence after their first operation outside of our hospital. No patient died due to tumor progression.Conclusions: Although survival is favorable with aggressive surgery, it is actually difficult to assess the prognostic factors of resected SPNs. Future investigations into the role of clinicopathological evaluation will unveil the prognostic enigma of pancreatic SPN after resection.Xinbo WangDaojun ZhuWei BaoMin LiSizhen WangRongxi ShenFrontiers Media S.A.articlemalignantpancreasprognosissolid pseudopapillary neoplasmsurgical managementSurgeryRD1-811ENFrontiers in Surgery, Vol 8 (2021)
institution DOAJ
collection DOAJ
language EN
topic malignant
pancreas
prognosis
solid pseudopapillary neoplasm
surgical management
Surgery
RD1-811
spellingShingle malignant
pancreas
prognosis
solid pseudopapillary neoplasm
surgical management
Surgery
RD1-811
Xinbo Wang
Daojun Zhu
Wei Bao
Min Li
Sizhen Wang
Rongxi Shen
Prognostic Enigma of Pancreatic Solid Pseudopapillary Neoplasm: A Single-Center Experience of 63 Patients
description Background: Studies investigating prognostic factors of solid pseudopapillary neoplasm (SPN) have been published with conflicting findings.Methods: Retrospective analysis of 63 consecutive cases of SPN in our institution from January 2010 to December 2019 was carried out. The clinicopathological features, treatment practices along with survival associations were collected and analyzed.Results: Fifteen patients (23.8%) were male, and 48 (76.2%) were female, with a median age of 34.0 ± 14.5 years. The larger tumor size was correlated with the more mixed components (p = 0.000) and the higher Ki-67 index (p = 0.042). No recurrence was found in the nine patients whose tumors fulfilled the WHO criteria for malignancy due to the presence of at least perineural invasion (6.4%), angiovascular invasion (2.3%), and/or adjacent organ invasion (6.4%). Microscopic infiltrative growth was detected in 9 (14.3%) tumors, which was correlated significantly with the WHO criteria (p = 0.002), capsule invasion (p = 0.005), and pancreatic parenchyma invasion (p = 0.001), but not with disease-free survival (p = 0.13). CD99 was found to be positively expressed in 88.9% (40/45) of tumors and more likely to have depressed Ki-67 index (p = 0.016). After a median follow-up of 58 months, only two patients (3.2%) had a recurrence after their first operation outside of our hospital. No patient died due to tumor progression.Conclusions: Although survival is favorable with aggressive surgery, it is actually difficult to assess the prognostic factors of resected SPNs. Future investigations into the role of clinicopathological evaluation will unveil the prognostic enigma of pancreatic SPN after resection.
format article
author Xinbo Wang
Daojun Zhu
Wei Bao
Min Li
Sizhen Wang
Rongxi Shen
author_facet Xinbo Wang
Daojun Zhu
Wei Bao
Min Li
Sizhen Wang
Rongxi Shen
author_sort Xinbo Wang
title Prognostic Enigma of Pancreatic Solid Pseudopapillary Neoplasm: A Single-Center Experience of 63 Patients
title_short Prognostic Enigma of Pancreatic Solid Pseudopapillary Neoplasm: A Single-Center Experience of 63 Patients
title_full Prognostic Enigma of Pancreatic Solid Pseudopapillary Neoplasm: A Single-Center Experience of 63 Patients
title_fullStr Prognostic Enigma of Pancreatic Solid Pseudopapillary Neoplasm: A Single-Center Experience of 63 Patients
title_full_unstemmed Prognostic Enigma of Pancreatic Solid Pseudopapillary Neoplasm: A Single-Center Experience of 63 Patients
title_sort prognostic enigma of pancreatic solid pseudopapillary neoplasm: a single-center experience of 63 patients
publisher Frontiers Media S.A.
publishDate 2021
url https://doaj.org/article/c49cef4a9fb54fb19e9e30fbb79a144a
work_keys_str_mv AT xinbowang prognosticenigmaofpancreaticsolidpseudopapillaryneoplasmasinglecenterexperienceof63patients
AT daojunzhu prognosticenigmaofpancreaticsolidpseudopapillaryneoplasmasinglecenterexperienceof63patients
AT weibao prognosticenigmaofpancreaticsolidpseudopapillaryneoplasmasinglecenterexperienceof63patients
AT minli prognosticenigmaofpancreaticsolidpseudopapillaryneoplasmasinglecenterexperienceof63patients
AT sizhenwang prognosticenigmaofpancreaticsolidpseudopapillaryneoplasmasinglecenterexperienceof63patients
AT rongxishen prognosticenigmaofpancreaticsolidpseudopapillaryneoplasmasinglecenterexperienceof63patients
_version_ 1718418185210822656